Patients band together to develop their own drugs
A real-world case study to set the scene Timothy Omer is a Type 1 diabetic and a ‘health hacker’. He, and others affected by this debilitating condition, have banded together under the #WeAreNotWaiting banner to develop their own solutions to their health issues. They have lost patience with an industry apparently failing to find answers […]
Keeping secrets in drug discovery
SMEs in the life sciences sector are the lifeblood of new innovations. If that’s you, it means that some of your most valuable assets will be your intellectual property and know-how. Most likely, you will have inventions which you are looking to patent, and other key confidential information. Inventions It is important to keep your […]
Putting the human back into medicines discovery
Is there something missing from your research? The need to humanise drug discovery was highlighted in the State of the Discovery Nation report. This is not surprising given that from the 63% of drugs that pass Phase I safety, only 31% pass Phase II human proof of concept and only 50% pass on through Phase […]
Biotech faces brighter, if more complex future
Catapult CEO Chris Molloy reflects on the latest trends and debates from BIO 2017 The world’s biotech community came together at BIO in San Diego last week. And, above the usual clamour of countries competing to promote their sectors – and their national cultures and delicacies (the Czech Republic even had a folk singer in […]
The importance of collaboration
A guest blog from Aisling Burnand, CEO of The Association of Medical Research Charities Collaboration can make all the difference to patients and their loved ones, and we need to work together to make it happen. I see collaboration as a powerful antidote to the challenges and barriers that face all of us in the […]
Catapult open for business to support UK drug discovery
New £1m facilities at University of Warwick open to support collaborative drug discovery, announces CEO Chris Molloy I am five months into my job as Chief Executive of the Medicines Discovery Catapult and I am delighted to be able to say we are now well and truly open for business to support and promote innovative, […]